Compounds and compositions for treating hematological disorders
US10758518B2 · kind B2 · utility
5Cited by
6References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 31, 2018 |
| Grant date | Sep 1, 2020 |
| Priority date | — |
| Expiry date | Oct 31, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of treating hematological disorders and solid malignant tumors, using substituted indazole compounds and pharmaceutically acceptable salts thereof. The compounds inhibit IRAK4 and BCL-2 kinases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.